- Home
- ZEO vs GTBP Comparison
ZEO vs GTBP Comparison
Compare ZEO & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEO
- GTBP
- Stock Information
- Founded
- ZEO 2005
- GTBP 1965
- Country
- ZEO United States
- GTBP United States
- Employees
- ZEO N/A
- GTBP N/A
- Industry
- ZEO
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- ZEO
- GTBP Health Care
- Exchange
- ZEO NYSE
- GTBP Nasdaq
- Market Cap
- ZEO 7.5M
- GTBP 6.6M
- IPO Year
- ZEO N/A
- GTBP N/A
- Fundamental
- Price
- ZEO $1.22
- GTBP $2.91
- Analyst Decision
- ZEO
- GTBP
- Analyst Count
- ZEO 0
- GTBP 0
- Target Price
- ZEO N/A
- GTBP N/A
- AVG Volume (30 Days)
- ZEO 39.4K
- GTBP 28.9K
- Earning Date
- ZEO 11-25-2024
- GTBP 11-14-2024
- Dividend Yield
- ZEO N/A
- GTBP N/A
- EPS Growth
- ZEO N/A
- GTBP N/A
- EPS
- ZEO 0.67
- GTBP N/A
- Revenue
- ZEO $95,455,763.00
- GTBP N/A
- Revenue This Year
- ZEO N/A
- GTBP N/A
- Revenue Next Year
- ZEO N/A
- GTBP N/A
- P/E Ratio
- ZEO $1.83
- GTBP N/A
- Revenue Growth
- ZEO N/A
- GTBP N/A
- 52 Week Low
- ZEO $1.05
- GTBP $1.92
- 52 Week High
- ZEO $11.60
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- ZEO 38.64
- GTBP 55.53
- Support Level
- ZEO $1.05
- GTBP $2.94
- Resistance Level
- ZEO $1.35
- GTBP $3.54
- Average True Range (ATR)
- ZEO 0.11
- GTBP 0.27
- MACD
- ZEO 0.01
- GTBP -0.02
- Stochastic Oscillator
- ZEO 26.62
- GTBP 23.05
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.